等待颈动脉内膜剥脱术期间神经复发风险低:丹麦多中心研究
术后30天大事件风险2.7%,与手术时机无显著相关。结论认为立即最佳药物治疗后早期但非紧急手术是合理策略。
要点
- 等待颈动脉内膜剥脱术期间同侧神经复发风险低(3.6%),无死亡或大卒中。
- 术后30天大事件(死亡或卒中)风险为2.7%,与手术时机无显著相关。
- 立即启动最佳药物治疗后早期但非紧急手术是合理策略。
核心结论
- 症状性颈动脉狭窄患者等待颈动脉内膜剥脱术期间神经复发风险很低,14天内发生率仅3.6%。
- 立即最佳药物治疗后早期但非紧急颈动脉内膜剥脱术是合理处理策略。
研究设计与样本
- 回顾性多中心观察性队列研究,纳入2014年1月1日至2018年12月31日丹麦四中心因症状性颈动脉狭窄计划行颈动脉内膜剥脱术的患者。
主要发现
- 从索引事件至手术中位延迟11天(IQR 8-16天),40例(3.6%;95%CI 2.5%-5%)发生神经复发。
- 神经复发中,短暂性脑缺血发作占55%(n=22),小卒中占30%(n=12),一过性黑矇占15%(n=6)。
- 术后30天大事件(死亡或卒中)Kaplan-Meier估计风险为2.7%(95%CI 1.8-3.8),与手术时机无显著相关,多数(69%)发生在术后前3天。
- 颈动脉内膜剥脱术患者1年、2年、3年死亡率(Kaplan-Meier估计)分别为4.8%、7.8%、11.5%。
关键数值与推荐
- 98%的患者在首次评估时启动了包含血小板抑制或抗凝药物及他汀的最佳药物治疗。
临床怎么用
- 对症状性颈动脉狭窄患者,应在专科TIA/卒中单元立即启动最佳药物治疗,随后安排早期但非紧急的颈动脉内膜剥脱术。
局限性
- 本研究为回顾性观察性设计,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice. METHODS: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (www.karbase.dk), operative managing systems, and electronic medical records were reviewed. RESULTS: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8-16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%-5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan-Meier [KM] estimate) 2.7% (95% CI 1.8-3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively. CONCLUSION: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.
引用
- Lawaetz M, Sandholt B, Eilersen EN, et al. Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study. Eur J Vasc Endovasc Surg. 2021. PMID: 34127375. doi:10.1016/j.ejvs.2021.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。